A Belgian hospital is now using a new scanner during surgery to immediately determine if all cancerous tissue has been removed, potentially reducing the need for additional treatments or repeat operations. The AZORG hospital in Aalst began utilizing the innovative technology on March 26, 2026, marking a significant advancement in surgical oncology.
The intra-operative PET-CT scanner allows surgeons to analyze removed tissue during the procedure itself, providing real-time feedback on the success of the tumor removal. This capability represents a major step forward in precision surgery and could improve patient outcomes.
“Thanks to the new scanner, surgeons at AZORG hospital can witness during the procedure whether a tumor has been completely removed,” according to reports. “This significantly reduces the chance of additional treatments or a second operation.”
The AZORG hospital’s implementation of this technology makes it the first in Belgium to offer intra-operative PET-CT scans during oncological procedures, specifically within the field of mouth, jaw, and facial surgery (MKA). More information about the hospital’s announcement is available on their website.
This development comes as the medical community continues to explore advanced imaging techniques and targeted therapies for cancer treatment. Recent research has also focused on utilizing the body’s own defense mechanisms to fight cancer, such as a study finding that a protective system against bacteria in fruit flies also kills tumor cells. Details of that research can be found on VRT NWS. Scientists are investigating new approaches like using molecular “Lego-blocks” to trigger self-destruction in cancer cells. Further information on this innovative therapy is available on VRT NWS.
The leverage of nuclear medicine in cancer treatment is also gaining traction, with Belgium developing an action plan to increase the use of radioactive medications delivered directly to tumors via the bloodstream. More on this initiative can be found on VRT NWS. The case highlights the ongoing commitment to innovation in the fight against cancer.
